Cerebellar Ataxia, Intellectual Disability, and Dysequilibrium Syndrome
Cerebellar ataxia, mental retardation, and dysequilibrium syndrome (CAMRQ) is a clinically and genetically heterogeneous group of rare autosomal-recessive non-progressive cerebellar disorders characterized by congenital ataxia, intellectual disability, severely delayed ambulation, and, in a subset of patients, quadrupedal locomotion. Cerebellar hypoplasia (predominantly of the inferior cerebellum and vermis) is the cardinal neuroimaging finding and pathologic substrate. Four genetic subtypes have been delineated: CAMRQ1 (VLDLR; Reelin signaling defect), CAMRQ2 (WDR81; BEACH-domain protein implicated in endolysosomal/autophagy regulation), CAMRQ3 (CA8; cerebellar carbonic anhydrase 8), and CAMRQ4 (ATP8A2; phosphatidylserine flippase). The syndrome was first described in consanguineous Hutterite and Turkish families. Management is supportive, with no disease-modifying therapy available.
Ask OpenScientist
Ask a research question about Cerebellar Ataxia, Intellectual Disability, and Dysequilibrium Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Inheritance
1Show evidence (1 reference)
Subtypes
4Show evidence (1 reference)
Show evidence (2 references)
Show evidence (1 reference)
Show evidence (1 reference)
Pathophysiology
6Show evidence (1 reference)
Show evidence (2 references)
Show evidence (2 references)
Show evidence (2 references)
Show evidence (1 reference)
Show evidence (1 reference)
Pathograph
Phenotypes
11Eye 1
Show evidence (1 reference)
Musculoskeletal 1
Show evidence (1 reference)
Nervous System 7
Show evidence (1 reference)
Show evidence (1 reference)
Show evidence (1 reference)
Show evidence (1 reference)
Show evidence (1 reference)
Show evidence (1 reference)
Show evidence (1 reference)
Other 2
Show evidence (2 references)
Show evidence (1 reference)
Genetic Associations
4Show evidence (1 reference)
Show evidence (2 references)
Show evidence (1 reference)
Show evidence (1 reference)
Treatments
3Source YAML
click to showname: Cerebellar Ataxia, Intellectual Disability, and Dysequilibrium Syndrome
creation_date: "2026-05-13T00:00:00Z"
updated_date: "2026-05-13T12:00:00Z"
category: Mendelian
description: >
Cerebellar ataxia, mental retardation, and dysequilibrium syndrome (CAMRQ) is a clinically
and genetically heterogeneous group of rare autosomal-recessive non-progressive cerebellar
disorders characterized by congenital ataxia, intellectual disability, severely delayed
ambulation, and, in a subset of patients, quadrupedal locomotion. Cerebellar hypoplasia
(predominantly of the inferior cerebellum and vermis) is the cardinal neuroimaging finding
and pathologic substrate. Four genetic subtypes have been delineated: CAMRQ1 (VLDLR;
Reelin signaling defect), CAMRQ2 (WDR81; BEACH-domain protein implicated in
endolysosomal/autophagy regulation), CAMRQ3 (CA8; cerebellar carbonic anhydrase 8), and
CAMRQ4 (ATP8A2; phosphatidylserine flippase). The syndrome was first described in
consanguineous Hutterite and Turkish families. Management is supportive, with no
disease-modifying therapy available.
disease_term:
preferred_term: cerebellar ataxia, intellectual disability, and dysequilibrium
term:
id: MONDO:0009133
label: cerebellar ataxia, intellectual disability, and dysequilibrium
parents:
- Mendelian Disorder
- Cerebellar disorder
- Cerebellar Hypoplasia
inheritance:
- name: Autosomal recessive
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
description: >
All four CAMRQ subtypes show autosomal recessive inheritance, with affected individuals
typically born to consanguineous parents. Founder homozygous variants are common.
evidence:
- reference: PMID:42051465
reference_title: "Identification of a Novel VLDLR Variant in the First Report of CAMRQ1 From Africa: Expanding the Spectrum of Cerebellar Ataxia Syndromes."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Cerebellar ataxia, mental retardation, and disequilibrium syndrome (CAMRQ)-related disorders are rare, nonprogressive, autosomal recessive conditions"
explanation: Recent review confirms autosomal recessive inheritance across the four CAMRQ subtypes.
has_subtypes:
- name: CAMRQ1
display_name: CAMRQ Type 1 (VLDLR)
description: >
CAMRQ1 (OMIM #224050) is caused by biallelic loss-of-function variants in VLDLR
(very-low-density lipoprotein receptor), a co-receptor in the Reelin signaling pathway
that guides neuronal migration during cerebellar and cortical development. First
described in a Hutterite kindred with a homozygous deletion of the entire VLDLR gene.
subtype_term:
preferred_term: cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1
term:
id: MONDO:0024542
label: cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1
evidence:
- reference: PMID:16080122
reference_title: "Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "A 199-kb homozygous deletion encompassing the entire very low density lipoprotein receptor (VLDLR) gene was present in all affected individuals."
explanation: First identification of VLDLR loss as the cause of the Hutterite CAMRQ1 phenotype.
- name: CAMRQ2
display_name: CAMRQ Type 2 (WDR81)
description: >
CAMRQ2 (OMIM #610185) is caused by biallelic variants in WDR81, encoding a
BEACH/WD40-repeat protein implicated in endolysosomal trafficking and selective
autophagy. Patients show congenital cerebellar ataxia, intellectual disability and,
in some, quadrupedal gait.
subtype_term:
preferred_term: cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2
term:
id: MONDO:0012430
label: cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2
evidence:
- reference: PMID:21885617
reference_title: "Homozygosity mapping and targeted genomic sequencing reveal the gene responsible for cerebellar hypoplasia and quadrupedal locomotion in a consanguineous kindred."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Targeted sequencing of the entire homozygous region in three affected individuals and two obligate carriers uncovered a private missense mutation, WDR81 p.P856L, which cosegregated with the condition in the extended family."
explanation: Original human identification of WDR81 as the CAMRQ2 gene in a consanguineous Turkish kindred with quadrupedal locomotion.
- reference: PMID:27390838
reference_title: "Characterization of a novel zebrafish (Danio rerio) gene, wdr81, associated with cerebellar ataxia, mental retardation and dysequilibrium syndrome (CAMRQ)."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "WDR81 (WD repeat-containing protein 81) is associated with cerebellar ataxia, mental retardation and disequilibrium syndrome (CAMRQ2, [MIM 610185])."
explanation: Zebrafish characterization study confirming WDR81 as the CAMRQ2 gene.
- name: CAMRQ3
display_name: CAMRQ Type 3 (CA8)
description: >
CAMRQ3 is caused by biallelic variants in CA8, encoding carbonic anhydrase 8, an
enzymatically inactive isoform highly expressed in cerebellar Purkinje cells that
modulates IP3-receptor calcium signaling. Recent series have refined the phenotype:
progressive cerebellar atrophy (especially superior vermis) and variable pyramidal
signs distinguish CA8-related disease from other CAMRQ subtypes.
subtype_term:
preferred_term: cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 3
term:
id: MONDO:0013188
label: cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 3
evidence:
- reference: PMID:38581205
reference_title: "Clinical and Molecular Spectrum of Autosomal Recessive CA8-Related Cerebellar Ataxia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "biallelic CA8 variants have currently been associated with a recessive neurological disorder named, cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3 (CAMRQ-3)."
explanation: Establishes CA8 as the gene for CAMRQ3 (CA8-related disorder).
- name: CAMRQ4
display_name: CAMRQ Type 4 (ATP8A2)
description: >
CAMRQ4 is caused by biallelic variants in ATP8A2, encoding a P4-type
phosphatidylserine flippase essential for neuronal membrane asymmetry. Phenotypes
range from severe encephalopathy with hypotonia, chorea/tremor and optic atrophy to
milder cerebellar ataxia without encephalopathy depending on residual flippase
activity.
subtype_term:
preferred_term: cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4
term:
id: MONDO:0014104
label: cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4
evidence:
- reference: PMID:31612321
reference_title: ATP8A2-related disorders as recessive cerebellar ataxia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "ATP8A2-related disorders are autosomal recessive conditions that associate encephalopathy with or without hypotonia, psychomotor delay, abnormal movements, chorea, tremor, optic atrophy and cerebellar atrophy (CARMQ4)."
explanation: Defines the ATP8A2-related CAMRQ4 phenotype and its severity spectrum.
pathophysiology:
- name: Cerebellar Hypoplasia and Purkinje Cell Dysfunction
description: >
A common downstream substrate across all four CAMRQ subtypes is impaired development
and/or function of the cerebellar cortex, with hypoplasia of the inferior cerebellum
and vermis. Purkinje cells — the sole output neuron of the cerebellar cortex — are
central targets: CA8 is enriched in Purkinje cells; ATP8A2 is required for Purkinje
cell membrane integrity; Reelin signaling via VLDLR governs Purkinje cell layer
formation.
cell_types:
- preferred_term: Purkinje cell
term:
id: CL:0000121
label: Purkinje cell
- preferred_term: cerebellar granule cell
term:
id: CL:0001031
label: cerebellar granule cell
biological_processes:
- preferred_term: cerebellum development
term:
id: GO:0021549
label: cerebellum development
modifier: DECREASED
- preferred_term: cerebellar cortex development
term:
id: GO:0021695
label: cerebellar cortex development
modifier: DECREASED
evidence:
- reference: PMID:16080122
reference_title: "Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "An autosomal recessive syndrome of nonprogressive cerebellar ataxia and mental retardation is associated with inferior cerebellar hypoplasia and mild cerebral gyral simplification in the Hutterite population."
explanation: Establishes inferior cerebellar hypoplasia as the cardinal neuroanatomical feature in CAMRQ1.
downstream:
- target: Cerebellar Motor and Cognitive Dysfunction
description: Reduced cerebellar output and disrupted cortico-cerebellar circuitry generate non-progressive ataxia, dysequilibrium and intellectual disability.
causal_link_type: DIRECT
evidence:
- reference: PMID:16080122
reference_title: "Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "An autosomal recessive syndrome of nonprogressive cerebellar ataxia and mental retardation is associated with inferior cerebellar hypoplasia"
explanation: Directly links cerebellar hypoplasia to the ataxia and intellectual disability phenotype.
- name: Disrupted Reelin Signaling (CAMRQ1)
description: >
VLDLR is a transmembrane receptor for the secreted glycoprotein Reelin. Reelin
signaling through VLDLR (and the paralog ApoER2) provides positional cues for
radially migrating neuroblasts in the developing cerebral cortex and cerebellum.
Loss of VLDLR — by homozygous deletion or pathogenic missense alleles that impair
plasma-membrane trafficking — disrupts Reelin-mediated neuronal migration and
cerebellar lamination, producing the CAMRQ1 phenotype.
biological_processes:
- preferred_term: reelin-mediated signaling pathway
term:
id: GO:0038026
label: reelin-mediated signaling pathway
modifier: DECREASED
- preferred_term: neuron migration
term:
id: GO:0001764
label: neuron migration
modifier: DECREASED
evidence:
- reference: PMID:16080122
reference_title: "Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "VLDLR is part of the reelin signaling pathway, which guides neuroblast migration in the cerebral cortex and cerebellum."
explanation: Mechanistically links VLDLR loss to disrupted Reelin signaling and neuronal migration.
- reference: PMID:42051465
reference_title: "Identification of a Novel VLDLR Variant in the First Report of CAMRQ1 From Africa: Expanding the Spectrum of Cerebellar Ataxia Syndromes."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "This ER retention is expected to disrupt VLDLR-mediated signaling pathways, including reelin signaling, thereby affecting neuronal migration."
explanation: Confirms ER-retained mutant VLDLR impairs Reelin signaling and neuronal migration in CAMRQ1.
downstream:
- target: Cerebellar Hypoplasia and Purkinje Cell Dysfunction
description: Defective Reelin signaling impairs cerebellar cortical lamination and Purkinje cell positioning.
causal_link_type: DIRECT
evidence:
- reference: PMID:16080122
reference_title: "Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "VLDLR is part of the reelin signaling pathway, which guides neuroblast migration in the cerebral cortex and cerebellum."
explanation: Direct mechanistic link from VLDLR/Reelin defect to disrupted cerebellar neuronal migration and hypoplasia.
- name: Endolysosomal Trafficking and Autophagy Defect (CAMRQ2)
description: >
WDR81 is a BEACH/WD40-repeat transmembrane protein expressed in developing brain,
including the Purkinje cell layer of the cerebellum. It is required for normal
endolysosomal membrane dynamics and selective autophagic clearance. Biallelic
loss-of-function or pathogenic missense variants (originally the homozygous
p.P856L allele in a consanguineous Turkish kindred) disrupt these vesicular and
autophagic processes in neurons, with secondary impact on cerebellar circuit
formation and Purkinje cell function.
cell_types:
- preferred_term: Purkinje cell
term:
id: CL:0000121
label: Purkinje cell
biological_processes:
- preferred_term: endosome organization
term:
id: GO:0007032
label: endosome organization
modifier: ABNORMAL
- preferred_term: autophagy
term:
id: GO:0006914
label: autophagy
modifier: ABNORMAL
evidence:
- reference: PMID:21885617
reference_title: "Homozygosity mapping and targeted genomic sequencing reveal the gene responsible for cerebellar hypoplasia and quadrupedal locomotion in a consanguineous kindred."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "It is highly expressed in the cerebellum and corpus callosum, in particular in the Purkinje cell layer of the cerebellum."
explanation: Establishes WDR81 expression in Purkinje cells, supporting a cell-autonomous cerebellar role.
- reference: PMID:27390838
reference_title: "Characterization of a novel zebrafish (Danio rerio) gene, wdr81, associated with cerebellar ataxia, mental retardation and dysequilibrium syndrome (CAMRQ)."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "zebrafish wdr81 is predicted to possess a BEACH (Beige and Chediak-Higashi) domain, a major facilitator superfamily domain and WD40-repeats, which indicates a conserved function in these species."
explanation: Conserved BEACH/WD40 domain architecture supports a role in endolysosomal/membrane trafficking and selective autophagy across vertebrates.
downstream:
- target: Cerebellar Hypoplasia and Purkinje Cell Dysfunction
description: WDR81 dysfunction impairs Purkinje cell endolysosomal and autophagic homeostasis, contributing to cerebellar hypoplasia and Purkinje cell dysfunction.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:21885617
reference_title: "Homozygosity mapping and targeted genomic sequencing reveal the gene responsible for cerebellar hypoplasia and quadrupedal locomotion in a consanguineous kindred."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "atrophy of superior, middle, and inferior peduncles of the cerebellum."
explanation: Links the WDR81 missense allele to cerebellar peduncle atrophy in affected individuals.
- name: Dysregulated Purkinje Cell Calcium Signaling (CAMRQ3)
description: >
CA8 (carbonic anhydrase 8) is an enzymatically inactive carbonic anhydrase isoform
enriched in cerebellar Purkinje cells. Biallelic loss-of-function CA8 variants
disrupt Purkinje cell calcium homeostasis and drive progressive cerebellar atrophy
(predominantly of the superior vermis) with ataxia, pyramidal signs, and
neurodevelopmental impairment.
cell_types:
- preferred_term: Purkinje cell
term:
id: CL:0000121
label: Purkinje cell
biological_processes:
- preferred_term: calcium-mediated signaling
term:
id: GO:0019722
label: calcium-mediated signaling
modifier: ABNORMAL
evidence:
- reference: PMID:38581205
reference_title: "Clinical and Molecular Spectrum of Autosomal Recessive CA8-Related Cerebellar Ataxia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Progressive selective cerebellar atrophy, predominantly affecting the superior vermis, was a key diagnostic finding in all patients."
explanation: Establishes the CA8-related progressive superior vermis atrophy phenotype consistent with Purkinje cell-autonomous dysfunction.
- reference: PMID:38581205
reference_title: "Clinical and Molecular Spectrum of Autosomal Recessive CA8-Related Cerebellar Ataxia."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Zebrafish models demonstrated impaired early neurodevelopment and motor behavior on ca8 knockout."
explanation: ca8-knockout zebrafish recapitulate impaired neurodevelopment and motor behaviour, supporting a cell-autonomous CA8 role.
downstream:
- target: Cerebellar Hypoplasia and Purkinje Cell Dysfunction
description: CA8 loss dysregulates Purkinje cell calcium homeostasis, driving Purkinje cell dysfunction and progressive cerebellar atrophy.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:38581205
reference_title: "Clinical and Molecular Spectrum of Autosomal Recessive CA8-Related Cerebellar Ataxia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "predominantly progressive cerebellar ataxia and pyramidal signs and variable bradykinesia, dystonia, and sensory impairment."
explanation: Connects CA8-related Purkinje cell dysfunction to the progressive cerebellar ataxia and pyramidal phenotype.
- name: Impaired Phospholipid Translocation in Neuronal Membranes (CAMRQ4)
description: >
ATP8A2 is a P4-type ATPase that catalyzes ATP-dependent translocation of
phosphatidylserine (and phosphatidylethanolamine) from the outer to the inner
leaflet of neuronal membranes, generating and maintaining lipid asymmetry essential
for membrane curvature, vesicle trafficking and neurite integrity. Most CAMRQ4
pathogenic missense variants produce protein with markedly reduced expression and
loss of phospholipid-activated ATPase activity, with residual activity correlating
with disease severity.
biological_processes:
- preferred_term: phospholipid translocation
term:
id: GO:0045332
label: phospholipid translocation
modifier: DECREASED
evidence:
- reference: PMID:31612321
reference_title: ATP8A2-related disorders as recessive cerebellar ataxia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Expression and functional studies of the missense mutations demonstrated that protein levels of four of the five missense variants were very low and lacked phosphatidylserine-activated ATPase activity."
explanation: Functional evidence that CAMRQ4 missense alleles abolish ATP8A2 phosphatidylserine-flippase activity.
downstream:
- target: Cerebellar Hypoplasia and Purkinje Cell Dysfunction
description: Loss of neuronal-membrane lipid asymmetry compromises Purkinje cell membrane integrity and cerebellar circuit function.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:31612321
reference_title: ATP8A2-related disorders as recessive cerebellar ataxia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "ATP8A2-related disorders are autosomal recessive conditions that associate encephalopathy with or without hypotonia, psychomotor delay, abnormal movements, chorea, tremor, optic atrophy and cerebellar atrophy (CARMQ4)."
explanation: Links ATP8A2 dysfunction to cerebellar atrophy and the broader CAMRQ4 neurologic phenotype.
- name: Cerebellar Motor and Cognitive Dysfunction
description: >
Convergent endpoint of CAMRQ pathophysiology: hypoplastic and dysfunctional
cerebellar circuitry produces non-progressive truncal and gait ataxia,
dysequilibrium, severely delayed ambulation (sometimes manifesting as quadrupedal
locomotion), and intellectual disability. Pyramidal signs and dysarthria are
variably present, particularly in CA8-related disease.
evidence:
- reference: PMID:42051465
reference_title: "Identification of a Novel VLDLR Variant in the First Report of CAMRQ1 From Africa: Expanding the Spectrum of Cerebellar Ataxia Syndromes."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Cerebellar ataxia, mental retardation, and disequilibrium syndrome (CAMRQ)-related disorders are rare, nonprogressive, autosomal recessive conditions primarily characterized by cerebellar ataxia, hypotonia, intellectual disability, delayed ambulation, and, in some cases, quadrupedal locomotion."
explanation: Recent review summarising the convergent clinical phenotype across CAMRQ subtypes.
phenotypes:
- name: Cerebellar Ataxia
category: Neurological
description: >
Non-progressive cerebellar ataxia is the cardinal motor manifestation, present
from infancy across all CAMRQ subtypes. CA8-related disease (CAMRQ3) may show
progressive cerebellar atrophy on imaging despite a relatively non-progressive
clinical course.
phenotype_term:
preferred_term: Ataxia
term:
id: HP:0001251
label: Ataxia
evidence:
- reference: PMID:42051465
reference_title: "Identification of a Novel VLDLR Variant in the First Report of CAMRQ1 From Africa: Expanding the Spectrum of Cerebellar Ataxia Syndromes."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "primarily characterized by cerebellar ataxia, hypotonia, intellectual disability, delayed ambulation"
explanation: Supports cerebellar ataxia as a cardinal feature of CAMRQ-related disorders.
- name: Intellectual Disability
category: Neurological
description: >
Intellectual disability ranges from mild to profound across CAMRQ subtypes, with
severe-to-profound forms most often reported in CAMRQ4 (ATP8A2).
phenotype_term:
preferred_term: Intellectual disability
term:
id: HP:0001249
label: Intellectual disability
evidence:
- reference: PMID:42051465
reference_title: "Identification of a Novel VLDLR Variant in the First Report of CAMRQ1 From Africa: Expanding the Spectrum of Cerebellar Ataxia Syndromes."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "primarily characterized by cerebellar ataxia, hypotonia, intellectual disability, delayed ambulation"
explanation: Supports intellectual disability as a defining feature of CAMRQ-related disorders.
- name: Cerebellar Hypoplasia
category: Neurological
description: >
Hypoplasia of the inferior cerebellum and vermis on MRI is the pathologic substrate
of CAMRQ. CAMRQ1 (VLDLR) classically shows inferior cerebellar hypoplasia with mild
cerebral gyral simplification; CAMRQ3 (CA8) often demonstrates progressive selective
cerebellar atrophy, especially of the superior vermis.
phenotype_term:
preferred_term: Cerebellar hypoplasia
term:
id: HP:0001321
label: Cerebellar hypoplasia
evidence:
- reference: PMID:16080122
reference_title: "Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "is associated with inferior cerebellar hypoplasia and mild cerebral gyral simplification in the Hutterite population."
explanation: Imaging evidence of inferior cerebellar hypoplasia in CAMRQ1.
- name: Delayed Ambulation
category: Neurological
description: >
Severely delayed independent ambulation is characteristic; some patients with CAMRQ
(notably CAMRQ1 and CAMRQ4) display quadrupedal locomotion in childhood.
phenotype_term:
preferred_term: Gait disturbance
term:
id: HP:0001288
label: Gait disturbance
evidence:
- reference: PMID:42051465
reference_title: "Identification of a Novel VLDLR Variant in the First Report of CAMRQ1 From Africa: Expanding the Spectrum of Cerebellar Ataxia Syndromes."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "primarily characterized by cerebellar ataxia, hypotonia, intellectual disability, delayed ambulation, and, in some cases, quadrupedal locomotion."
explanation: Supports delayed ambulation (with occasional quadrupedal locomotion) as a defining feature.
- name: Global Developmental Delay
category: Neurological
description: >
Severe global (motor and cognitive) developmental delay, frequently with associated
encephalopathy, is the CAMRQ4-distinguishing developmental phenotype. ATP8A2-related
disorders include psychomotor delay and encephalopathy beyond the intellectual
disability seen across all CAMRQ subtypes.
phenotype_term:
preferred_term: Global developmental delay
term:
id: HP:0001263
label: Global developmental delay
subtype: CAMRQ4
evidence:
- reference: PMID:31612321
reference_title: ATP8A2-related disorders as recessive cerebellar ataxia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "ATP8A2-related disorders are autosomal recessive conditions that associate encephalopathy with or without hypotonia, psychomotor delay, abnormal movements, chorea, tremor, optic atrophy and cerebellar atrophy (CARMQ4)."
explanation: Supports severe psychomotor delay with encephalopathy as a CAMRQ4-distinguishing developmental phenotype.
- name: Hypotonia
category: Neurological
description: >
Hypotonia is a defining clinical feature of CAMRQ-related disorders, present from
infancy and contributing to delayed motor milestones.
phenotype_term:
preferred_term: Generalized hypotonia
term:
id: HP:0001290
label: Generalized hypotonia
evidence:
- reference: PMID:42051465
reference_title: "Identification of a Novel VLDLR Variant in the First Report of CAMRQ1 From Africa: Expanding the Spectrum of Cerebellar Ataxia Syndromes."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "primarily characterized by cerebellar ataxia, hypotonia, intellectual disability, delayed ambulation"
explanation: Recent review identifies hypotonia as a primary clinical feature of CAMRQ-related disorders.
- name: Quadrupedal Locomotion
category: Neurological
description: >
Quadrupedal locomotion (walking on hands and feet) is a clinically distinctive but
not obligate feature of CAMRQ. Most prominently reported in CAMRQ1 (VLDLR) and
CAMRQ2 (WDR81) consanguineous kindreds, it occurs in a subset of CA8-related
patients as well.
phenotype_term:
preferred_term: Cerebellar ataxia associated with quadrupedal gait
term:
id: HP:0009878
label: Cerebellar ataxia associated with quadrupedal gait
evidence:
- reference: PMID:42051465
reference_title: "Identification of a Novel VLDLR Variant in the First Report of CAMRQ1 From Africa: Expanding the Spectrum of Cerebellar Ataxia Syndromes."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "delayed ambulation, and, in some cases, quadrupedal locomotion."
explanation: Establishes quadrupedal locomotion as a clinically distinctive subset feature of CAMRQ.
- reference: PMID:21885617
reference_title: "Homozygosity mapping and targeted genomic sequencing reveal the gene responsible for cerebellar hypoplasia and quadrupedal locomotion in a consanguineous kindred."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "WDR81 represents the third gene, after VLDLR and CA8, implicated in quadrupedal locomotion in humans."
explanation: Supports quadrupedal locomotion as a CAMRQ feature shared across VLDLR, CA8, and WDR81 genetic subtypes.
- name: Progressive Cerebellar Vermis Atrophy
category: Neurological
description: >
CAMRQ3 (CA8-related) is distinguished from other CAMRQ subtypes by progressive
selective cerebellar atrophy on serial imaging, predominantly affecting the
superior vermis. This is in contrast to the largely non-progressive inferior
cerebellar hypoplasia seen in CAMRQ1.
phenotype_term:
preferred_term: Progressive superior vermis atrophy
term:
id: HP:0006855
label: Cerebellar vermis atrophy
clinical_course: PROGRESSIVE
subtype: CAMRQ3
evidence:
- reference: PMID:38581205
reference_title: "Clinical and Molecular Spectrum of Autosomal Recessive CA8-Related Cerebellar Ataxia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Progressive selective cerebellar atrophy, predominantly affecting the superior vermis, was a key diagnostic finding in all patients."
explanation: CA8-specific progressive superior vermis atrophy as a key diagnostic imaging feature.
- name: Chorea
category: Neurological
description: >
Chorea (involuntary, irregular, jerky movements) is one of the abnormal movement
phenotypes reported in ATP8A2-related CAMRQ4. Together with tremor and other
abnormal movements, chorea is part of the CAMRQ4-distinguishing movement disorder
spectrum not typically seen in CAMRQ1-3.
phenotype_term:
preferred_term: Chorea
term:
id: HP:0002072
label: Chorea
subtype: CAMRQ4
evidence:
- reference: PMID:31612321
reference_title: ATP8A2-related disorders as recessive cerebellar ataxia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "ATP8A2-related disorders are autosomal recessive conditions that associate encephalopathy with or without hypotonia, psychomotor delay, abnormal movements, chorea, tremor, optic atrophy and cerebellar atrophy (CARMQ4)."
explanation: Identifies chorea as part of the CAMRQ4-distinguishing abnormal movement spectrum.
- name: Tremor
category: Neurological
description: >
Tremor is part of the abnormal movement spectrum reported in ATP8A2-related
CAMRQ4 and helps distinguish CAMRQ4 from the other CAMRQ subtypes.
phenotype_term:
preferred_term: Tremor
term:
id: HP:0001337
label: Tremor
subtype: CAMRQ4
evidence:
- reference: PMID:31612321
reference_title: ATP8A2-related disorders as recessive cerebellar ataxia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "ATP8A2-related disorders are autosomal recessive conditions that associate encephalopathy with or without hypotonia, psychomotor delay, abnormal movements, chorea, tremor, optic atrophy and cerebellar atrophy (CARMQ4)."
explanation: Identifies tremor as part of the CAMRQ4-distinguishing abnormal movement spectrum.
- name: Optic Atrophy
category: Neurological
description: >
Optic atrophy is reported in ATP8A2-related CAMRQ4 and is clinically important
for ophthalmologic surveillance. It is a distinguishing feature of CAMRQ4 not
characteristic of the other CAMRQ subtypes.
phenotype_term:
preferred_term: Optic atrophy
term:
id: HP:0000648
label: Optic atrophy
subtype: CAMRQ4
evidence:
- reference: PMID:31612321
reference_title: ATP8A2-related disorders as recessive cerebellar ataxia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "ATP8A2-related disorders are autosomal recessive conditions that associate encephalopathy with or without hypotonia, psychomotor delay, abnormal movements, chorea, tremor, optic atrophy and cerebellar atrophy (CARMQ4)."
explanation: Identifies optic atrophy as a CAMRQ4 feature that warrants ophthalmologic surveillance.
genetic:
- name: VLDLR mutations (CAMRQ1)
association: Causative
notes: >
Biallelic loss-of-function variants in VLDLR (very-low-density lipoprotein receptor)
cause CAMRQ1. The originally described Hutterite kindred carried a 199-kb homozygous
deletion encompassing the entire VLDLR gene. Missense variants that retain mutant
VLDLR protein in the endoplasmic reticulum (impairing plasma-membrane trafficking
and Reelin signaling) have subsequently been reported worldwide.
gene_term:
preferred_term: VLDLR
term:
id: hgnc:12698
label: VLDLR
subtype: CAMRQ1
evidence:
- reference: PMID:16080122
reference_title: "Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "A 199-kb homozygous deletion encompassing the entire very low density lipoprotein receptor (VLDLR) gene was present in all affected individuals."
explanation: Identifies VLDLR loss as the cause of CAMRQ1 in the original Hutterite cohort.
- name: WDR81 mutations (CAMRQ2)
association: Causative
notes: >
Biallelic variants in WDR81, encoding a BEACH-domain WD40-repeat protein, cause
CAMRQ2. WDR81 is implicated in endolysosomal trafficking and selective autophagy and
is expressed in developing brain including Purkinje cells. The gene was originally
mapped in a consanguineous Turkish family with quadrupedal locomotion and
cerebro-cerebellar hypoplasia.
gene_term:
preferred_term: WDR81
term:
id: hgnc:26600
label: WDR81
subtype: CAMRQ2
evidence:
- reference: PMID:21885617
reference_title: "Homozygosity mapping and targeted genomic sequencing reveal the gene responsible for cerebellar hypoplasia and quadrupedal locomotion in a consanguineous kindred."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "WDR81 represents the third gene, after VLDLR and CA8, implicated in quadrupedal locomotion in humans."
explanation: Original human genetic identification of WDR81 as the third CAMRQ gene in a consanguineous Turkish kindred.
- reference: PMID:27390838
reference_title: "Characterization of a novel zebrafish (Danio rerio) gene, wdr81, associated with cerebellar ataxia, mental retardation and dysequilibrium syndrome (CAMRQ)."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "WDR81 (WD repeat-containing protein 81) is associated with cerebellar ataxia, mental retardation and disequilibrium syndrome (CAMRQ2, [MIM 610185])."
explanation: Zebrafish characterization supports the conserved role of WDR81 in CAMRQ2.
- name: CA8 mutations (CAMRQ3)
association: Causative
notes: >
Biallelic variants in CA8 (carbonic anhydrase 8), an enzymatically inactive isoform
enriched in cerebellar Purkinje cells that modulates IP3-receptor calcium signaling,
cause CAMRQ3. The CA8-related phenotype is distinguished by progressive selective
cerebellar atrophy (predominantly superior vermis) and frequent pyramidal signs.
gene_term:
preferred_term: CA8
term:
id: hgnc:1382
label: CA8
subtype: CAMRQ3
evidence:
- reference: PMID:38581205
reference_title: "Clinical and Molecular Spectrum of Autosomal Recessive CA8-Related Cerebellar Ataxia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "biallelic CA8 variants have currently been associated with a recessive neurological disorder named, cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3 (CAMRQ-3)."
explanation: Confirms biallelic CA8 variants as causative for CAMRQ3.
- name: ATP8A2 mutations (CAMRQ4)
association: Causative
notes: >
Biallelic variants in ATP8A2, encoding a P4-type phosphatidylserine flippase, cause
CAMRQ4. Most pathogenic missense variants reduce protein expression and abolish
phospholipid-activated ATPase activity; rare variants that retain partial activity
are associated with milder ataxia phenotypes without encephalopathy.
gene_term:
preferred_term: ATP8A2
term:
id: hgnc:13533
label: ATP8A2
subtype: CAMRQ4
evidence:
- reference: PMID:31612321
reference_title: ATP8A2-related disorders as recessive cerebellar ataxia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we identified six point mutations (one splice site and five missense mutations) involving ATP8A2 in six individuals from five families."
explanation: Confirms ATP8A2 variants as causative for CAMRQ4 in a multi-family cohort.
treatments:
- name: Supportive Care
description: >
No disease-modifying therapy exists for any CAMRQ subtype. Management is symptomatic
and supportive — special education, speech/language therapy, mobility aids, treatment
of comorbid epilepsy where present, and routine surveillance for orthopaedic and
ophthalmologic complications. Genetic counselling is recommended for affected
families.
treatment_term:
preferred_term: supportive care
term:
id: MAXO:0000950
label: supportive care
- name: Physical Therapy
description: >
Long-term physiotherapy and occupational therapy are mainstays of CAMRQ management,
aimed at improving gait, balance, posture, and functional independence.
treatment_term:
preferred_term: physical therapy
term:
id: MAXO:0000011
label: physical therapy
- name: Genetic Counselling
description: >
Because all four CAMRQ subtypes are autosomal recessive and most cases occur in
consanguineous families, genetic counselling — including carrier testing and
reproductive counselling — is an important component of care.
treatment_term:
preferred_term: genetic counseling
term:
id: MAXO:0000079
label: genetic counseling
datasets: []
References & Deep Research
Deep Research
2Cerebellar Ataxia, Intellectual Disability, and Dysequilibrium Syndrome (CAMRQ / Dysequilibrium Syndrome): Comprehensive Research Report
Target disease
- Disease name (preferred): Cerebellar ataxia, intellectual disability, and dysequilibrium (CAMRQ spectrum) (beaudin2019thenosologyof pages 27-28, OpenTargets Search: Dysequilibrium syndrome,cerebellar ataxia intellectual disability dysequilibrium syndrome)
- Category: Mendelian, neurodevelopmental disorder; typically autosomal recessive (beaudin2019thenosologyof pages 27-28, boycott2009mutationsinvldlr pages 1-2)
- MONDO ID: MONDO:0009133 (disease group) (OpenTargets Search: Dysequilibrium syndrome,cerebellar ataxia intellectual disability dysequilibrium syndrome)
- Orphanet ID: Orphanet:1766 (“Dysequilibrium syndrome”) (OpenTargets Search: Dysequilibrium syndrome,cerebellar ataxia intellectual disability dysequilibrium syndrome)
Executive summary (current understanding)
CAMRQ (also historically called dysequilibrium syndrome, DES) is a genetically heterogeneous group of congenital/early-onset neurodevelopmental disorders characterized by cerebellar ataxia/disequilibrium with intellectual disability and variable neuroimaging abnormalities (most classically inferior cerebellar hypoplasia with simplified gyration in VLDLR-associated disease, but MRI can be normal in ATP8A2-associated disease). Core pathophysiology differs by subtype but converges on disrupted neurodevelopmental circuitry (neuronal migration/synapse development for VLDLR; membrane lipid asymmetry/neuronal maintenance for ATP8A2; cerebellar circuit development for CA8; endosomal/autophagy-linked neuronal homeostasis for WDR81). Management is currently supportive (rehabilitation, educational support, feeding/respiratory management, symptomatic seizure management). (boycott2009mutationsinvldlr pages 1-2, boycott2009mutationsinvldlr pages 2-4, alsahli2018furtherdelineationof pages 1-2, narishige2022twosiblingswith pages 1-2, hochman2025cerebellarataxiaimpaired pages 1-2)
1. Disease information
1.1 What is the disease?
Dysequilibrium syndrome/CAMRQ is described as an autosomal recessive genetically heterogeneous condition with congenital onset, non-progressive cerebellar ataxia, disequilibrium, and intellectual disability, associated with cerebellar hypoplasia in many cases. (wali2021broadeningtheclinical pages 1-2, boycott2009mutationsinvldlr pages 1-2)
Direct abstract quote (authoritative definition): - “Dysequilibrium syndrome (DES) is an autosomal recessive genetically heterogeneous condition characterized clinically by congenital onset of non-progressive cerebellar ataxia, disturbed equilibrium and mental retardation associated with cerebellar hypoplasia.” (Movement Disorders Clinical Practice; May 2021; https://doi.org/10.1002/mdc3.13184) (wali2021broadeningtheclinical pages 1-2)
1.2 Key identifiers and synonyms
A harmonized identifier map supported by OpenTargets (for MONDO/Orphanet) and ataxia nosology literature (for OMIM subtype mapping) is summarized here:
| Concept | Preferred name | Synonyms | MONDO ID | Orphanet ID | OMIM phenotype number | Causal gene(s) | Inheritance | Key notes |
|---|---|---|---|---|---|---|---|---|
| Disease group | Cerebellar ataxia, intellectual disability, and dysequilibrium | Dysequilibrium syndrome; DES; CAMRQ; cerebellar ataxia with mental retardation and dysequilibrium | MONDO:0009133 | Orphanet:1766 | — | Genetically heterogeneous; key mapped genes include VLDLR, WDR81, CA8, ATP8A2 | Autosomal recessive | OpenTargets links MONDO:0009133 to VLDLR, WDR81, CA8, ATP8A2 and Orphanet:1766 corresponds to dysequilibrium syndrome; core phenotype is congenital/early-onset ataxia with impaired intellectual development and disequilibrium (OpenTargets Search: Dysequilibrium syndrome,cerebellar ataxia intellectual disability dysequilibrium syndrome, beaudin2019thenosologyof pages 27-28, beaudin2019thenosologyof pages 57-57) |
| Disease group | Dysequilibrium syndrome | DES; CAMRQ; cerebellar ataxia, intellectual disability, and dysequilibrium | — | Orphanet:1766 | — | VLDLR, WDR81, CA8, ATP8A2 | Autosomal recessive | Orphanet disease entity used in OpenTargets; aggregates the genetically heterogeneous CAMRQ spectrum (OpenTargets Search: Dysequilibrium syndrome,cerebellar ataxia intellectual disability dysequilibrium syndrome, beaudin2019thenosologyof pages 27-28) |
| Subtype | Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 | CAMRQ1; VLDLR-associated dysequilibrium syndrome; VLDLR-associated cerebellar hypoplasia | — | — | 224050 | VLDLR | Autosomal recessive | Typically non-progressive; associated with inferior cerebellar hypoplasia and cortical gyral simplification; historically a major cause of DES (beaudin2019thenosologyof pages 27-28, boycott2009mutationsinvldlr pages 2-4, boycott2009mutationsinvldlr pages 1-2) |
| Subtype | Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 | CAMRQ2; DES2 | MONDO:0012430 | — | 610185 | WDR81 | Autosomal recessive | MONDO subtype in OpenTargets; reported with cerebellar/corpus callosum hypoplasia and variable quadrupedal gait in published families (OpenTargets Search: Dysequilibrium syndrome,cerebellar ataxia intellectual disability dysequilibrium syndrome, hochman2025cerebellarataxiaimpaired pages 1-2, beaudin2019thenosologyof pages 27-28) |
| Subtype | Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 3 | CAMRQ3 | — | — | 613227 | CA8 | Autosomal recessive | CA8-related subtype; MRI findings can include cerebellar atrophy and white matter abnormalities, although imaging may be variable (beaudin2019thenosologyof pages 27-28) |
| Subtype | Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4 | CAMRQ4 | — | — | 615268 | ATP8A2 | Autosomal recessive | ATP8A2-related subtype; often severe early-onset neuromotor disorder with hypotonia, developmental delay, abnormal movements, and sometimes normal brain MRI despite marked disability (beaudin2019thenosologyof pages 27-28, teov2023compoundheterozygosityin pages 1-3, alsahli2018furtherdelineationof pages 1-2) |
Table: This table summarizes the disease-group and subtype nomenclature for cerebellar ataxia, intellectual disability, and dysequilibrium syndrome, including MONDO, Orphanet, OMIM, and gene mappings. It is useful for harmonizing disease knowledge base entries across aggregated rare-disease resources and subtype-specific literature.
Notes on missing identifiers: This tool-based evidence set did not contain explicit ICD-10/ICD-11 or MeSH IDs for CAMRQ/DES; these should be sourced from OMIM/Orphanet/MeSH directly during curation (not retrievable in the current evidence set). (beaudin2019thenosologyof pages 27-28, OpenTargets Search: Dysequilibrium syndrome,cerebellar ataxia intellectual disability dysequilibrium syndrome)
1.3 Data provenance (individual vs aggregated)
- Aggregated resources: OpenTargets associations connecting Dysequilibrium syndrome (Orphanet:1766) and CAMRQ MONDO terms to genes (ATP8A2, VLDLR, WDR81, CA8) (OpenTargets Search: Dysequilibrium syndrome,cerebellar ataxia intellectual disability dysequilibrium syndrome).
- Individual/family-level primary clinical genetics: numerous family/case-series reports for VLDLR-DES and ATP8A2-CAMRQ4 and rarer WDR81/CA8 subtypes (boycott2009mutationsinvldlr pages 1-2, narishige2022twosiblingswith pages 1-2, alsahli2018furtherdelineationof pages 1-2, hochman2025cerebellarataxiaimpaired pages 1-2).
2. Etiology
2.1 Disease causal factors
Primary cause is genetic (Mendelian, autosomal recessive) with multiple subtype genes: - CAMRQ1: VLDLR (VLDLR-associated cerebellar hypoplasia/dysequilibrium syndrome) (beaudin2019thenosologyof pages 27-28, boycott2009mutationsinvldlr pages 1-2) - CAMRQ2: WDR81 (beaudin2019thenosologyof pages 27-28, hochman2025cerebellarataxiaimpaired pages 1-2) - CAMRQ3: CA8 (beaudin2019thenosologyof pages 27-28, richmond2020cerebellarataxiawith pages 6-11) - CAMRQ4: ATP8A2 (beaudin2019thenosologyof pages 27-28, alsahli2018furtherdelineationof pages 1-2)
2.2 Risk factors
- Consanguinity is frequently reported for CAMRQ4 cohorts (e.g., “consanguinity in 90%” in one CAMRQ4 cohort) (alsahli2018furtherdelineationof pages 1-2).
- Population clustering/founder effects are reported for specific VLDLR variants (e.g., Hutterite population; founder mutation in Oman) (boycott2009mutationsinvldlr pages 1-2, ali2012amissensefounder pages 1-3).
2.3 Protective factors
No validated genetic or environmental protective factors were identified in the retrieved evidence.
2.4 Gene–environment interactions
No CAMRQ-specific gene–environment interactions were identified in the retrieved evidence.
3. Phenotypes
3.1 Core clinical phenotype and frequencies (with HPO)
Quantitative phenotype frequencies are best described for CAMRQ4 (ATP8A2) cohorts; VLDLR-DES has classic imaging plus selected frequency estimates (e.g., seizures). A phenotype/HPO mapping table with frequencies is provided:
| Phenotype (plain language) | Suggested HPO term(s) | Typical onset/course | Notes | Reported frequency (with numerator/denominator when available) | Most-associated subtype/gene | Key citation |
|---|---|---|---|---|---|---|
| Global developmental delay | HP:0001263 Global developmental delay | Infancy; usually persistent, non-progressive developmental impairment | Core feature across CAMRQ; often first recognized in infancy | 33/33 (100%) in compiled CAMRQ4 cohort | CAMRQ4 / ATP8A2 | (narishige2022twosiblingswith pages 4-5, alsahli2018furtherdelineationof pages 1-2) |
| Intellectual disability / impaired intellectual development | HP:0001249 Intellectual disability | Early childhood onward; persistent, severity variable | Often moderate to profound in VLDLR-DES; may be milder in some subtype-specific cases | 29/33 (88%) in CAMRQ4; moderate-to-profound commonly described in VLDLR-DES | All subtypes; especially CAMRQ1 / VLDLR and CAMRQ4 / ATP8A2 | (narishige2022twosiblingswith pages 4-5, boycott2009mutationsinvldlr pages 2-4, boycott2009mutationsinvldlr pages 1-2) |
| Feeding difficulty | HP:0011968 Feeding difficulties | Infancy; may persist in severe cases | Common in severe CAMRQ4 and contributes to disability burden | 22/26 (85%) in CAMRQ4 | CAMRQ4 / ATP8A2 | (narishige2022twosiblingswith pages 4-5, narishige2022twosiblingswith pages 1-2) |
| Non-ambulatory / inability to walk independently | HP:0002540 Unable to walk; HP:0002509 Abnormality of gait | Infancy/childhood; usually chronic, some achieve limited ambulation | Delayed or absent walking is a defining feature; quadrupedal locomotion may occur in some families | 29/33 (88%) non-ambulatory in CAMRQ4; only 40% achieved ambulation at least once in another cohort | CAMRQ4 / ATP8A2; also seen in CAMRQ1-3 | (narishige2022twosiblingswith pages 4-5, alsahli2018furtherdelineationof pages 1-2, wali2021broadeningtheclinical pages 1-2) |
| Hypotonia | HP:0001252 Muscular hypotonia; HP:0001290 Generalized hypotonia | Neonatal/infantile onset; often persistent | Truncal hypotonia is particularly emphasized in VLDLR-DES and severe CAMRQ4 | 28/32 (88%) in CAMRQ4; 100% in one CAMRQ4 cohort | CAMRQ4 / ATP8A2; CAMRQ1 / VLDLR | (narishige2022twosiblingswith pages 4-5, alsahli2018furtherdelineationof pages 1-2, wali2021broadeningtheclinical pages 1-2) |
| Chorea / choreoathetosis / dyskinetic movements | HP:0002072 Chorea; HP:0001266 Choreoathetosis | Infancy or early childhood; persistent but variable | Helpful clue for CAMRQ4, sometimes mimics dyskinetic cerebral palsy early on | 22/27 (81%) in CAMRQ4; abnormal movements 50% in one cohort | CAMRQ4 / ATP8A2 | (narishige2022twosiblingswith pages 4-5, narishige2022twosiblingswith pages 1-2, alsahli2018furtherdelineationof pages 1-2) |
| Lack of sitting and/or head control | HP:0001270 Motor delay; HP:0002429 Complete lack of development of motor skills; HP:0010869 Inability to lift head | Infancy; persistent in severe cases | Marker of severe neuromotor involvement | 20/30 (73%) in CAMRQ4 | CAMRQ4 / ATP8A2 | (narishige2022twosiblingswith pages 4-5, narishige2022twosiblingswith pages 1-2) |
| Cerebellar ataxia / truncal ataxia / disequilibrium | HP:0001251 Ataxia; HP:0002066 Gait ataxia; HP:0002078 Truncal ataxia | Congenital or infancy-onset; usually non-progressive or slowly evolving | Core syndrome-defining feature across all CAMRQ subtypes | 17/20 (85%) in CAMRQ4; 100% in one CAMRQ4 cohort | All subtypes; classic in CAMRQ1 / VLDLR | (narishige2022twosiblingswith pages 4-5, alsahli2018furtherdelineationof pages 1-2, boycott2009mutationsinvldlr pages 2-4) |
| Optic atrophy / visual pathway involvement | HP:0000648 Optic atrophy | Childhood; may emerge over time | More prominent in ATP8A2-related disease than in classic VLDLR-DES | 16/27 (59%) in CAMRQ4 | CAMRQ4 / ATP8A2 | (narishige2022twosiblingswith pages 4-5, narishige2022twosiblingswith pages 1-2) |
| Ophthalmoplegia / abnormal eye movements | HP:0000602 Ophthalmoplegia; HP:0000508 Abnormality of eye movement | Infancy/childhood; persistent | Ocular motor abnormalities are recurrent in CAMRQ4 and abnormal ocular movements are also reported in DES broadly | 13/26 (50%) in CAMRQ4 | CAMRQ4 / ATP8A2 | (narishige2022twosiblingswith pages 4-5, narishige2022twosiblingswith pages 1-2, micalizzi2016verymildfeatures pages 1-2) |
| Seizures | HP:0001250 Seizure | Variable; may occur in childhood | Not universal; historically reported in VLDLR-DES cohorts, absent in some later pedigrees | ~40% in reviewed VLDLR-DES patients | CAMRQ1 / VLDLR | (boycott2009mutationsinvldlr pages 1-2, wali2021broadeningtheclinical pages 1-2) |
| Short stature | HP:0004322 Short stature | Childhood; persistent | Minor but reported associated feature in VLDLR-DES | ~15% in reviewed VLDLR-DES patients | CAMRQ1 / VLDLR | (boycott2009mutationsinvldlr pages 1-2) |
| Cerebellar atrophy on MRI | HP:0001272 Cerebellar atrophy | Usually detected in childhood imaging; may be absent early | More variable in ATP8A2 disease than in VLDLR-DES; some CAMRQ4 patients have normal MRI | 6/31 (19%) in CAMRQ4 | CAMRQ4 / ATP8A2 | (narishige2022twosiblingswith pages 4-5, alsahli2018furtherdelineationof pages 1-2) |
| Cerebral atrophy on MRI | HP:0002059 Cerebral atrophy | Variable | Seen in a minority of CAMRQ4 cases | 5/31 (16%) in CAMRQ4 | CAMRQ4 / ATP8A2 | (narishige2022twosiblingswith pages 4-5) |
| Thin / hypotrophic corpus callosum on MRI | HP:0002079 Hypoplasia of the corpus callosum; HP:0001273 Agenesis of corpus callosum (broader differential) | Variable; developmental structural finding | Reported in CAMRQ4 and CAMRQ2; may accompany white matter changes | 5/31 (16%) in CAMRQ4 | CAMRQ4 / ATP8A2; CAMRQ2 / WDR81 | (narishige2022twosiblingswith pages 4-5, teov2023compoundheterozygosityin pages 1-3, hochman2025cerebellarataxiaimpaired pages 1-2) |
| Delayed myelination on MRI | HP:0002188 Delayed CNS myelination | Infancy/childhood | Supports neurodevelopmental disorder; not specific | 3/31 (10%) in CAMRQ4 | CAMRQ4 / ATP8A2 | (narishige2022twosiblingswith pages 4-5, teov2023compoundheterozygosityin pages 1-3, narishige2022twosiblingswith pages 1-2) |
| Inferior cerebellar hypoplasia pattern on MRI | HP:0001321 Cerebellar hypoplasia; HP:0011329 Vermis hypoplasia | Congenital structural malformation; typically stable | Classic radiologic signature of VLDLR-DES involving inferior vermis and hemispheres | Qualitative hallmark; frequency not consistently enumerated in extracted text | CAMRQ1 / VLDLR | (boycott2009mutationsinvldlr pages 2-4, boycott2009mutationsinvldlr pages 1-2, boycott2009mutationsinvldlr media 6fdfc298) |
| Pontine hypoplasia / small pons on MRI | HP:0007366 Small pons; HP:0001306 Pontine hypoplasia | Congenital structural malformation; typically stable | Often accompanies VLDLR-related cerebellar hypoplasia | Qualitative hallmark; frequency not consistently enumerated in extracted text | CAMRQ1 / VLDLR | (boycott2009mutationsinvldlr pages 2-4, boycott2009mutationsinvldlr pages 1-2, boycott2009mutationsinvldlr media 6fdfc298) |
| Simplified gyration / cortical sulcal simplification on MRI | HP:0009879 Simplified gyral pattern; HP:0009875 Abnormal cerebral gyration | Congenital developmental brain malformation | In VLDLR-DES, cortical sulcation is simplified with mildly thickened cortex | Qualitative hallmark; frequency not consistently enumerated in extracted text | CAMRQ1 / VLDLR | (boycott2009mutationsinvldlr pages 2-4, boycott2009mutationsinvldlr pages 1-2, boycott2009mutationsinvldlr media 6fdfc298) |
Table: This table summarizes the most consistently reported clinical and MRI phenotypes across CAMRQ/dysequilibrium syndrome, with HPO mappings and subtype associations. It emphasizes quantitative frequencies from CAMRQ4 cohorts and the classic neuroradiologic pattern of VLDLR-associated disease.
3.2 Key neuroradiologic signature (VLDLR subtype)
VLDLR-associated disease has a recognizable MRI pattern including inferior cerebellar vermis/hemisphere hypoplasia and simplified gyration. Figure-level evidence was captured from Boycott et al. (2009) showing these characteristic findings. (boycott2009mutationsinvldlr media 6fdfc298)
3.3 Quality-of-life impact
Direct quality-of-life instrument data (EQ-5D/SF-36/PROMIS) were not identified in the retrieved literature. However, the high frequency of non-ambulation and feeding difficulties in CAMRQ4 indicates substantial functional dependence. (narishige2022twosiblingswith pages 4-5, narishige2022twosiblingswith pages 2-4)
4. Genetic / molecular information
4.1 Causal genes
Causal gene mapping for the CAMRQ spectrum is supported by ataxia nosology and OpenTargets disease–gene associations (beaudin2019thenosologyof pages 27-28, OpenTargets Search: Dysequilibrium syndrome,cerebellar ataxia intellectual disability dysequilibrium syndrome).
4.2 Pathogenic variants (examples) and functional class
Representative pathogenic variants and mechanistic themes are summarized:
| Subtype | Gene (HGNC symbol) | Example pathogenic variants mentioned in evidence (HGVS c./p.) | Variant class | Molecular mechanism summary | Key pathway/process (with suggested GO terms) | Evidence type | Key citation |
|---|---|---|---|---|---|---|---|
| CAMRQ1 / VLDLR-associated dysequilibrium syndrome | VLDLR | c.1561G>C p.(Asp521His); c.1711_1712dupT p.(Tyr571Leufs*7) | Missense; frameshift | Biallelic VLDLR loss impairs receptor function in the Reelin pathway, disrupting neuronal migration and producing inferior cerebellar hypoplasia, small pons, and simplified gyration | Reelin signaling; neuronal migration; cerebellar development (GO:0001764 neuron migration, GO:0021549 cerebellum development, GO:0030335 positive regulation of cell migration) | Human case-series; neuroimaging; molecular genetics | (boycott2009mutationsinvldlr pages 2-4, boycott2009mutationsinvldlr pages 1-2, boycott2009mutationsinvldlr media 6fdfc298) |
| CAMRQ1 / VLDLR-associated dysequilibrium syndrome | VLDLR | c.658_743del p.(Asp220Trpfs*6) | Frameshift | Predicted loss-of-function/truncation causing VLDLR deficiency; associated with classic DES plus broadened phenotype including varied locomotor patterns, truncal hypotonia, focal dystonia, and ocular telangiectasia in one large family | Reelin signaling; neuronal migration; synaptogenesis/synaptic plasticity (GO:0001764, GO:0048167 regulation of synaptic plasticity, GO:0050808 synapse organization) | Human family study / case-series | (wali2021broadeningtheclinical pages 1-2) |
| CAMRQ4 | ATP8A2 | c.1741C>T p.(Arg581); c.2158C>T p.(Arg720) | Nonsense; nonsense | Truncating ATP8A2 variants cause loss of a neuronal P4-ATPase phospholipid flippase required for membrane lipid asymmetry; linked to severe early-onset neuromotor disorder, sensory impairment, and profound developmental disability | Aminophospholipid translocation; membrane lipid asymmetry; neuron survival (GO:0140148 phospholipid transport, GO:0006869 lipid transport, GO:0048678 response to axon injury/neuronal maintenance related) | Human case report / family genetics | (narishige2022twosiblingswith pages 1-2) |
| CAMRQ4 | ATP8A2 | p.(Leu538Pro) | Missense | Missense change in the nucleotide-binding/ATPase domain causing near-complete loss of protein expression, consistent with protein misfolding and ATPase loss-of-function; associated with ataxia, spasticity, nystagmus, and thin corpus callosum | Phospholipid translocation; protein folding quality control; vesicle trafficking (GO:0140148, GO:0006457 protein folding, GO:0016192 vesicle-mediated transport) | Human family study with functional interpretation | (flannery2024anovelmissense pages 1-5) |
| CAMRQ4 | ATP8A2 | p.(Gly447Arg); p.(Ala772Pro); p.(Glu459Gln); p.(Arg1147Trp) | Missense | Functional cell studies showed Gly447Arg and Ala772Pro are low-expression/mislocalized misfolding variants causing CAMRQ4; Glu459Gln had wild-type behavior and is likely non-causative; Arg1147Trp retained partial function and may confer a milder phenotype | Protein folding; Golgi/endosome localization; ATPase activity; membrane trafficking (GO:0006457, GO:0006886 intracellular protein transport, GO:0140148) | Functional cell assay / in vitro | (matsell2024functionalandin pages 1-3) |
| CAMRQ3 | CA8 | c.232C>T p.(Arg78*) | Nonsense | Truncating CA8 variant is predicted to undergo nonsense-mediated decay, causing loss of carbonic anhydrase VIII/CARP8 function; model data support disrupted granule-cell proliferation and Purkinje-cell circuit patterning as the basis of ataxia | Cerebellar Purkinje cell development; regulation of intracellular calcium signaling; cerebellar circuit patterning (GO:0021549 cerebellum development, GO:0051480 regulation of cytosolic calcium ion concentration, GO:0061564 axon development/circuit organization related) | Human case report; model organism support (wdl mouse) | (richmond2020cerebellarataxiawith pages 6-11) |
| CAMRQ2 | WDR81 | c.2567C>T p.(Pro856Leu) | Missense | Homozygous WDR81 missense variant associated with CAMRQ2; human phenotype includes cerebellar ataxia, hypotonia, mild nystagmus, and cerebellar atrophy. Broader functional literature implicates WDR81 in neuronal development, endosomal maturation, and autophagic clearance of aggregates | Autophagy; endosome maturation; neuronal viability (GO:0006914 autophagy, GO:0006897 endocytosis, GO:0043524 negative regulation of neuron apoptotic process / cell viability related) | Human case report; supporting functional/model literature | (hochman2025cerebellarataxiaimpaired pages 1-2, matsell2025characterizingthefunctiona pages 108-112) |
Table: This table summarizes representative CAMRQ subtype genes, example pathogenic variants, and the main mechanistic themes supported by human and functional evidence. It is useful for linking subtype-specific variants to shared and distinct neurodevelopmental pathways relevant to diagnosis and interpretation.
Key examples: - VLDLR (CAMRQ1): compound heterozygous variants p.(Asp521His) and p.(Tyr571Leufs7) reported as causal in non-Hutterite family; consistent with autosomal recessive disease (Journal of Child Neurology; Mar 2009; https://doi.org/10.1177/0883073809332696) (boycott2009mutationsinvldlr pages 2-4, boycott2009mutationsinvldlr media 6fdfc298). - ATP8A2 (CAMRQ4): compound heterozygous truncating variants p.(Arg581) and p.(Arg720*) in severe early-onset cases (Tohoku J Exp Med; Mar 2022; https://doi.org/10.1620/tjem.2022.j010) (narishige2022twosiblingswith pages 1-2).
4.3 Variant class, population frequency, and somatic/germline
- Evidence supports germline biallelic pathogenic variants as causal; somatic mechanisms are not implicated in the retrieved CAMRQ evidence. (boycott2009mutationsinvldlr pages 1-2, narishige2022twosiblingswith pages 1-2)
- This evidence set did not include allele frequencies from gnomAD/ExAC; such frequencies require external database query.
4.4 Modifier genes / epigenetics
No validated modifier genes or CAMRQ-specific epigenetic signatures were identified in the retrieved evidence.
5. Environmental information
No CAMRQ-specific environmental, lifestyle, or infectious causal factors were identified in the retrieved evidence; CAMRQ is best supported as a primary genetic neurodevelopmental disorder. (wali2021broadeningtheclinical pages 1-2, alsahli2018furtherdelineationof pages 1-2)
6. Mechanism / pathophysiology
6.1 Unifying disease model (causal chain)
- Biallelic loss-of-function or deleterious missense variants in subtype genes (VLDLR/WDR81/CA8/ATP8A2). (beaudin2019thenosologyof pages 27-28, boycott2009mutationsinvldlr pages 1-2)
- Gene-specific molecular dysfunction:
- VLDLR: impaired Reelin signaling affecting neuronal migration and cortical/cerebellar development (boycott2009mutationsinvldlr pages 2-4, onat2012identificationofatp8a2a pages 155-159).
- ATP8A2: impaired P4-ATPase lipid flippase activity and/or protein misfolding, disrupting membrane asymmetry, vesicle trafficking, and neuronal maintenance (alsahli2018furtherdelineationof pages 1-2, matsell2024functionalandin pages 1-3, narishige2022twosiblingswith pages 1-2).
- CA8: loss of CA8 function (often via NMD) with downstream disruption of cerebellar circuit development; mouse data supports Purkinje/granule-cell circuit effects (richmond2020cerebellarataxiawith pages 6-11).
- WDR81: associated with CAMRQ2; broader functional literature links WDR81 to neuronal homeostasis mechanisms including autophagy/endosomal biology (hochman2025cerebellarataxiaimpaired pages 1-2, matsell2025characterizingthefunctiona pages 108-112).
- Systems-level neurodevelopmental outcomes: cerebellar hypoplasia/atrophy and altered cerebro-cerebellar circuitry.
- Clinical manifestations: congenital/early onset ataxia/disequilibrium, delayed/absent ambulation (sometimes quadrupedal locomotion), hypotonia, and intellectual disability. (boycott2009mutationsinvldlr pages 1-2, narishige2022twosiblingswith pages 4-5)
6.2 Pathways and suggested ontology terms
- VLDLR/Reelin pathway: neuronal migration and cerebellar development.
- Suggested GO: GO:0001764 (neuron migration), GO:0021549 (cerebellum development).
- ATP8A2 lipid flipping / membrane asymmetry: phospholipid transport and protein folding quality control when misfolding.
- Suggested GO: GO:0006869 (lipid transport), GO:0006457 (protein folding).
- CA8 cerebellar circuit development: Purkinje/granule-cell development.
- Suggested GO: GO:0021549 (cerebellum development).
6.3 Cell types (Cell Ontology suggestions)
Evidence in this set implicates cerebellar circuitry and (for CA8) Purkinje cell circuit patterning; suggested CL terms: - Purkinje neuron: CL:0000121 - Cerebellar granule cell: CL:0000120
6.4 Molecular profiling / omics
No CAMRQ-specific transcriptomic/proteomic/metabolomic cohort profiling was retrieved. A CA8 case report highlighted FDG-PET hypometabolism as a potential early marker despite normal MRI, but this is imaging-metabolic rather than molecular omics. (paternoster2020novelhomozygousvariant pages 1-2)
7. Anatomical structures affected
7.1 Organ/system level
- Primary system: central nervous system—cerebellum and associated brainstem/cortical development (boycott2009mutationsinvldlr pages 2-4, boycott2009mutationsinvldlr media 6fdfc298).
7.2 Tissue/cell level
- Cerebellar cortex circuits (Purkinje and granule cell-related circuitry) (richmond2020cerebellarataxiawith pages 6-11).
7.3 Subcellular level (selected)
- ATP8A2-related: plasma membrane/Golgi/endosome lipid asymmetry and protein folding/trafficking (alsahli2018furtherdelineationof pages 1-2, matsell2024functionalandin pages 1-3).
7.4 UBERON suggestions
- Cerebellum: UBERON:0002037
- Cerebellar vermis: UBERON:0001305
- Pons: UBERON:0000974
8. Temporal development
- Onset: typically congenital/infancy. (boycott2009mutationsinvldlr pages 1-2, wali2021broadeningtheclinical pages 1-2)
- Course: often characterized as non-progressive (particularly in classic DES/VLDLR descriptions), but severity and evolution vary; some CAMRQ4 reports note degenerative features in imaging summaries. (micalizzi2016verymildfeatures pages 1-2, narishige2022twosiblingswith pages 4-5)
9. Inheritance and population
9.1 Inheritance
- Predominantly autosomal recessive across subtypes (VLDLR, WDR81, CA8, ATP8A2). (beaudin2019thenosologyof pages 27-28, alsahli2018furtherdelineationof pages 1-2, hochman2025cerebellarataxiaimpaired pages 1-2)
9.2 Epidemiology and populations (limited quantitative prevalence data)
Formal prevalence/incidence estimates were not identified in the retrieved evidence. Published case aggregates suggest extreme rarity: - For VLDLR-associated DES, one report noted “Approximately 50 genetically proven cases have been published to date” (as of May 2021). (wali2021broadeningtheclinical pages 1-2) - CAMRQ2 has been described as “fewer than 20 published cases” in a recent case report (note: case-report statement). (hochman2025cerebellarataxiaimpaired pages 1-2)
Reported populations/founder contexts include: - North American Hutterites (historic VLDLR deletion cohort), and additional families with Turkish, Iranian, Iraqi, Caucasian, Indian, and Omani background. (boycott2009mutationsinvldlr pages 1-2, wali2021broadeningtheclinical pages 1-2, ali2012amissensefounder pages 1-3)
10. Diagnostics
A practical diagnostic and differential approach is summarized here:
| Diagnostic domain | Findings/tests | When used | Notes/pitfalls | Evidence source |
|---|---|---|---|---|
| Neurologic exam and developmental assessment | Congenital/early infantile hypotonia, truncal/cerebellar ataxia, delayed ambulation or non-ambulation, intellectual/developmental impairment, dysarthria, abnormal gait including quadrupedal or crawling patterns; assess head control, sitting, speech, coordination, ocular movements | First-line at initial clinical suspicion in infants/children with developmental delay and disequilibrium | Core syndrome is often recognizable clinically, but severity is variable across subtypes; some CAMRQ2/CAMRQ4 cases are milder than classic descriptions | (boycott2009mutationsinvldlr pages 2-4, boycott2009mutationsinvldlr pages 1-2, alsahli2018furtherdelineationof pages 1-2, hochman2025cerebellarataxiaimpaired pages 1-2) |
| Brain MRI: classic VLDLR-pattern | Inferior cerebellar vermis and hemisphere hypoplasia, small pons/brainstem, simplified cortical sulcation/gyral pattern, mildly thickened cortex | Early neuroimaging in children with congenital ataxia/intellectual disability | Highly suggestive of VLDLR-associated disease (CAMRQ1), but not all CAMRQ subtypes share this pattern | (boycott2009mutationsinvldlr pages 2-4, boycott2009mutationsinvldlr pages 1-2, boycott2009mutationsinvldlr media 6fdfc298) |
| Brain MRI: ATP8A2-pattern | MRI may be normal or only mildly abnormal; reported findings include cerebellar atrophy, cerebral atrophy, thin/hypotrophic corpus callosum, delayed myelination, ventriculomegaly | Use in suspected CAMRQ4, especially when phenotype is severe but diagnosis unclear | Normal MRI does not exclude CAMRQ4; one cohort reported normal brain MRI in 60% of patients, so overreliance on MRI can delay diagnosis | (alsahli2018furtherdelineationof pages 1-2, narishige2022twosiblingswith pages 4-5, teov2023compoundheterozygosityin pages 1-3, narishige2022twosiblingswith pages 1-2, flannery2024anovelmissense pages 1-5) |
| Brain MRI: WDR81/CAMRQ2 pattern | Cerebellar atrophy or hypoplasia, corpus callosum hypoplasia/atrophy, generalized brain atrophy; vermian-predominant cerebellar atrophy in some cases | Use when CAMRQ2 is in differential for congenital ataxia with ID and gait abnormality | CAMRQ2 is very rare and neuroradiology may overlap with other cerebellar malformation syndromes | (hochman2025cerebellarataxiaimpaired pages 1-2) |
| Ophthalmology | Fundoscopy/ophthalmic exam for optic atrophy, retinal degeneration, abnormal ocular movements, strabismus, ophthalmoplegia | Early in workup when CAMRQ4 or broader CAMRQ is suspected | Visual system involvement is particularly helpful for recognizing ATP8A2-related disease; ocular motor abnormalities also occur in other CAMRQ subtypes | (narishige2022twosiblingswith pages 1-2, narishige2022twosiblingswith pages 4-5, micalizzi2016verymildfeatures pages 1-2, boycott2009mutationsinvldlr pages 2-4) |
| Audiology | Auditory brainstem response (ABR) testing | When severe developmental delay/hypotonia with possible sensory impairment is present, especially in CAMRQ4 | Abnormal or flattened ABR can support ATP8A2-related disease and help distinguish from isolated cerebral palsy-like presentations | (narishige2022twosiblingswith pages 1-2) |
| Electrophysiology | Somatosensory evoked potentials (SSEP); targeted EEG if seizures suspected | Adjunctive testing in severe CAMRQ4 or unexplained neurodevelopmental disorder | Flattened cortical SSEPs were reported in CAMRQ4; electrophysiology is supportive rather than diagnostic | (narishige2022twosiblingswith pages 1-2) |
| Metabolic screening | Plasma/CSF biochemistry, urine organic acids/GC-MS, other metabolic tests to exclude treatable neurometabolic disorders | Early exclusionary step in infants/children with hypotonia, ataxia, developmental delay | Often normal in genetically confirmed CAMRQ; useful mainly to rule out mimics before/alongside genomic testing | (narishige2022twosiblingswith pages 1-2, richmond2020cerebellarataxiawith pages 6-11) |
| Genetic testing strategy | Whole-exome sequencing (WES) or broad ataxia/neurodevelopmental panel; trio testing when possible; segregation by Sanger sequencing in relatives; ACMG/AMP variant classification; CNV analysis when indicated | Recommended once syndromic congenital ataxia/dysequilibrium is recognized or MRI/clinical clues suggest CAMRQ | Broad sequencing is especially important because CAMRQ is genetically heterogeneous (VLDLR, WDR81, CA8, ATP8A2) and MRI may be normal in CAMRQ4; reanalysis can be informative in rare subtypes | (alsahli2018furtherdelineationof pages 1-2, teov2023compoundheterozygosityin pages 1-3, richmond2020cerebellarataxiawith pages 6-11, hochman2025cerebellarataxiaimpaired pages 1-2) |
| Differential diagnosis: dyskinetic cerebral palsy | Early non-progressive hypotonia, dyskinesia/choreoathetosis, severe motor delay may resemble dyskinetic CP | Consider during initial pediatric neurology assessment, especially in infancy | CAMRQ4 can mimic dyskinetic cerebral palsy early; associated visual/hearing impairment, family history/consanguinity, and genomic testing help distinguish it | (narishige2022twosiblingswith pages 1-2) |
| Differential diagnosis: hereditary/nonprogressive congenital ataxias and cerebellar malformations | Distinguish from other recessive ataxias, pontocerebellar hypoplasia spectrum, Joubert-related disorders, and CA8-related ataxia with normal intellect | Use after initial MRI and exam narrow to congenital cerebellar disorder | Imaging-phenotype discordance can occur, especially CA8 and ATP8A2 cases with normal or subtle MRI findings | (richmond2020cerebellarataxiawith pages 6-11, paternoster2020novelhomozygousvariant pages 1-2, alsahli2018furtherdelineationof pages 1-2) |
| Diagnostic counseling/real-world implementation | Use molecular diagnosis to inform prognosis, recurrence risk, family testing, and educational/rehabilitative planning | After confirmation of pathogenic/likely pathogenic variants | Published cases document supportive services (special education, daily care support, PT in some cases), but no disease-specific diagnostic biomarker or targeted therapy is established | (richmond2020cerebellarataxiawith pages 6-11, narishige2022twosiblingswith pages 1-2, hochman2025cerebellarataxiaimpaired pages 1-2) |
Table: This table summarizes the practical diagnostic workup and key differential diagnoses for cerebellar ataxia, intellectual disability, and dysequilibrium syndrome across major subtypes. It highlights where MRI is informative, where it may be misleading, and why broad genomic testing is central to diagnosis.
Key points for real-world implementation: - MRI pattern can be highly informative for VLDLR disease (inferior cerebellar hypoplasia + simplified gyration) (boycott2009mutationsinvldlr media 6fdfc298). - Normal MRI does not exclude CAMRQ4 (ATP8A2), and WES may be indicated even when imaging is non-diagnostic. (alsahli2018furtherdelineationof pages 1-2) - CAMRQ4 can mimic dyskinetic cerebral palsy early; sensory involvement (vision/hearing) and genomic testing help resolve diagnosis. (narishige2022twosiblingswith pages 1-2)
11. Outcome / prognosis
- Functional outcomes are variable by subtype and variant severity.
- In a CAMRQ4 cohort, severe disability was common and 2/10 deaths were attributed to “recurrent respiratory infection.” (alsahli2018furtherdelineationof pages 3-5)
- CAMRQ2 case report suggested early diagnosis and therapies may contribute to milder presentation and “more favorable outcome” (author interpretation). (hochman2025cerebellarataxiaimpaired pages 2-3)
12. Treatment
12.1 Current standard of care (supportive)
No disease-modifying pharmacotherapy was identified in the retrieved evidence; care is symptomatic and supportive: - Rehabilitation therapies: physical therapy / occupational therapy (CAMRQ2 case). (hochman2025cerebellarataxiaimpaired pages 1-2) - Educational supports: tutoring/special needs schooling and structured daily care support described in CAMRQ2 and CAMRQ4 cases. (hochman2025cerebellarataxiaimpaired pages 1-2, narishige2022twosiblingswith pages 1-2) - Seizure management: valproic acid used for suspected epilepsy in CAMRQ4. (narishige2022twosiblingswith pages 1-2) - Feeding management: feeding adaptations and monitoring for choking/feeding difficulty are described (CAMRQ2/CAMRQ4). (hochman2025cerebellarataxiaimpaired pages 1-2, narishige2022twosiblingswith pages 1-2)
12.2 MAXO term suggestions (for knowledge base annotation)
- Physical therapy: MAXO:0000010
- Occupational therapy: MAXO:0000011
- Speech therapy evaluation/therapy: MAXO:0000012
- Antiseizure medication therapy: MAXO:0001026 (broad category; exact MAXO mapping may vary by ontology version)
- Special education services: MAXO:0000127 (or related educational intervention term; verify in MAXO version used)
12.3 Experimental / targeted therapies
No CAMRQ-specific interventional clinical trials were identified in the retrieved ClinicalTrials.gov query results; hits appeared unrelated to CAMRQ genetics and likely reflect the ambiguity of “disequilibrium” as a symptom term. (clinical trials tool output; no CAMRQ-relevant trial context IDs available)
13. Prevention
Primary prevention is not established (genetic disease), but recurrence risk reduction is feasible through: - Genetic counseling after molecular diagnosis. - Carrier testing and reproductive planning; one CA8 case explicitly noted the diagnosis “informed reproductive planning.” (richmond2020cerebellarataxiawith pages 6-11)
14. Other species / natural disease
No naturally occurring veterinary CAMRQ/DES analogs were identified in the retrieved evidence.
15. Model organisms
Model evidence supports subtype mechanisms: - CA8: spontaneous wdl mouse model supports CA8 loss-of-function with ataxic phenotype and cerebellar circuit abnormalities (Purkinje/granule cell patterning). (richmond2020cerebellarataxiawith pages 6-11) - ATP8A2: mouse data summarized in foundational ATP8A2 work indicates neurologic phenotypes (ataxia/tremor) and axonal transport defects with Atp8a2 deficiency. (onat2012identificationofatp8a2 pages 155-159)
Recent developments (prioritizing 2023–2024)
- 2024 functional interpretation of ATP8A2 variants (CAMRQ4): Disease Models & Mechanisms (Apr 2024; https://doi.org/10.1242/dmm.050546) experimentally distinguished misfolding variants from likely non-causative variants, supporting improved variant interpretation and (future) proteostasis-directed rescue strategies. (matsell2024functionalandin pages 1-3)
- 2024 CAMRQ4 missense variant spectrum expansion: Neurogenetics (Jul 2024; https://doi.org/10.1007/s10048-024-00773-9) reported a novel ATP8A2 missense variant p.(Leu538Pro) with near-complete loss of protein expression and described diffusion MRI abnormalities, broadening imaging correlates. (flannery2024anovelmissense pages 1-5)
- 2023 CAMRQ4 case report with novel compound heterozygosity: PRILOZI (Dec 2023; https://doi.org/10.2478/prilozi-2023-0051) reported a novel ATP8A2 frameshift in trans with a known stop variant, with white matter/corpus callosum abnormalities on MRI, adding to the allelic spectrum. (teov2023compoundheterozygosityin pages 1-3)
Limitations of this tool-based report
- ICD-10/ICD-11 and MeSH identifiers, gnomAD allele frequencies, and comprehensive epidemiology (prevalence/incidence) were not present in the retrieved evidence set and should be added by querying the recommended external resources (OMIM, Orphanet, MeSH, gnomAD) during knowledge base population.
- CAMRQ subtypes 2 and 3 are underrepresented in the retrieved primary literature compared with CAMRQ1 and CAMRQ4; additional targeted retrieval may be needed for complete frequency tables outside ATP8A2 cohorts.
References
-
(beaudin2019thenosologyof pages 27-28): M Beaudin. The nosology of hereditary cerebellar ataxias: development of a classification for recessive ataxias and phenotypical description of spinocerebellar ataxia 34. Unknown journal, 2019.
-
(OpenTargets Search: Dysequilibrium syndrome,cerebellar ataxia intellectual disability dysequilibrium syndrome): Open Targets Query (Dysequilibrium syndrome,cerebellar ataxia intellectual disability dysequilibrium syndrome, 17 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
-
(boycott2009mutationsinvldlr pages 1-2): Kym M. Boycott, Carsten Bonnemann, Joachim Herz, Stephanie Neuert, Chandree Beaulieu, James N. Scott, Anuradha Venkatasubramanian, and Jillian S. Parboosingh. Mutations in vldlr as a cause for autosomal recessive cerebellar ataxia with mental retardation (dysequilibrium syndrome). Journal of Child Neurology, 24:1310-1315, Mar 2009. URL: https://doi.org/10.1177/0883073809332696, doi:10.1177/0883073809332696. This article has 80 citations and is from a peer-reviewed journal.
-
(boycott2009mutationsinvldlr pages 2-4): Kym M. Boycott, Carsten Bonnemann, Joachim Herz, Stephanie Neuert, Chandree Beaulieu, James N. Scott, Anuradha Venkatasubramanian, and Jillian S. Parboosingh. Mutations in vldlr as a cause for autosomal recessive cerebellar ataxia with mental retardation (dysequilibrium syndrome). Journal of Child Neurology, 24:1310-1315, Mar 2009. URL: https://doi.org/10.1177/0883073809332696, doi:10.1177/0883073809332696. This article has 80 citations and is from a peer-reviewed journal.
-
(alsahli2018furtherdelineationof pages 1-2): Saud Alsahli, Muhammad Talal Alrifai, Saeed Al Tala, Fuad Al Mutairi, and Majid Alfadhel. Further delineation of the clinical phenotype of cerebellar ataxia, mental retardation, and disequilibrium syndrome type 4. Journal of Central Nervous System Disease, Feb 2018. URL: https://doi.org/10.1177/1179573518759682, doi:10.1177/1179573518759682. This article has 30 citations and is from a peer-reviewed journal.
-
(narishige2022twosiblingswith pages 1-2): Yuta Narishige, Hisao Yaoita, Moriei Shibuya, Miki Ikeda, Kaori Kodama, Aritomo Kawashima, Yukimune Okubo, Wakaba Endo, Takehiko Inui, Noriko Togashi, Soichiro Tanaka, Yasuko Kobayashi, Akira Onuma, Jun Takayama, Gen Tamiya, Atsuo Kikuchi, Shigeo Kure, and Kazuhiro Haginoya. Two siblings with cerebellar ataxia, mental retardation, and disequilibrium syndrome 4 and a novel variant of atp8a2. The Tohoku journal of experimental medicine, 256:321-326, Mar 2022. URL: https://doi.org/10.1620/tjem.2022.j010, doi:10.1620/tjem.2022.j010. This article has 13 citations.
-
(hochman2025cerebellarataxiaimpaired pages 1-2): Livia Hochman, Alrick Drummond, and Kara Morgan. Cerebellar ataxia, impaired intellectual development, and disequilibrium syndrome-2: a case report. Cureus, Jan 2025. URL: https://doi.org/10.7759/cureus.78066, doi:10.7759/cureus.78066. This article has 0 citations.
-
(wali2021broadeningtheclinical pages 1-2): Gurusidheshwar M. Wali and Gautam Wali. Broadening the clinical spectrum of very low density lipoprotein receptor associated dysequilibrium syndrome. Movement Disorders Clinical Practice, 8:619-623, May 2021. URL: https://doi.org/10.1002/mdc3.13184, doi:10.1002/mdc3.13184. This article has 2 citations and is from a peer-reviewed journal.
-
(beaudin2019thenosologyof pages 57-57): M Beaudin. The nosology of hereditary cerebellar ataxias: development of a classification for recessive ataxias and phenotypical description of spinocerebellar ataxia 34. Unknown journal, 2019.
-
(teov2023compoundheterozygosityin pages 1-3): Bojan Teov, Aleksandra Janchevska, Ardiana Beqiri-Jasari, Velibor Tasic, Goran Kungulovski, and Zoran Gucev. Compound heterozygosity in cerebellar ataxia, mental retardation, and disequilibrium syndrome type 4. PRILOZI, 44:85-90, Dec 2023. URL: https://doi.org/10.2478/prilozi-2023-0051, doi:10.2478/prilozi-2023-0051. This article has 0 citations.
-
(richmond2020cerebellarataxiawith pages 6-11): Christopher M. Richmond, Richard Leventer, Monique M. Ryan, and Martin B. Delatycki. Cerebellar ataxia with normal intellect associated with a homozygous truncating variant in ca8. Clinical Genetics, 97:516-520, Nov 2020. URL: https://doi.org/10.1111/cge.13666, doi:10.1111/cge.13666. This article has 6 citations and is from a peer-reviewed journal.
-
(ali2012amissensefounder pages 1-3): Bassam R Ali, Jennifer L Silhavy, Matthew J Gleeson, Joseph G Gleeson, and Lihadh Al-Gazali. A missense founder mutation in vldlr is associated with dysequilibrium syndrome without quadrupedal locomotion. BMC Medical Genetics, 13:80-80, Sep 2012. URL: https://doi.org/10.1186/1471-2350-13-80, doi:10.1186/1471-2350-13-80. This article has 44 citations and is from a peer-reviewed journal.
-
(narishige2022twosiblingswith pages 4-5): Yuta Narishige, Hisao Yaoita, Moriei Shibuya, Miki Ikeda, Kaori Kodama, Aritomo Kawashima, Yukimune Okubo, Wakaba Endo, Takehiko Inui, Noriko Togashi, Soichiro Tanaka, Yasuko Kobayashi, Akira Onuma, Jun Takayama, Gen Tamiya, Atsuo Kikuchi, Shigeo Kure, and Kazuhiro Haginoya. Two siblings with cerebellar ataxia, mental retardation, and disequilibrium syndrome 4 and a novel variant of atp8a2. The Tohoku journal of experimental medicine, 256:321-326, Mar 2022. URL: https://doi.org/10.1620/tjem.2022.j010, doi:10.1620/tjem.2022.j010. This article has 13 citations.
-
(micalizzi2016verymildfeatures pages 1-2): Alessia Micalizzi, Isabella Moroni, Monia Ginevrino, Tommaso Biagini, Tommaso Mazza, Marta Romani, and Enza Maria Valente. Very mild features of dysequilibrium syndrome associated with a novel vldlr missense mutation. neurogenetics, 17:191-195, Jun 2016. URL: https://doi.org/10.1007/s10048-016-0488-y, doi:10.1007/s10048-016-0488-y. This article has 10 citations and is from a peer-reviewed journal.
-
(boycott2009mutationsinvldlr media 6fdfc298): Kym M. Boycott, Carsten Bonnemann, Joachim Herz, Stephanie Neuert, Chandree Beaulieu, James N. Scott, Anuradha Venkatasubramanian, and Jillian S. Parboosingh. Mutations in vldlr as a cause for autosomal recessive cerebellar ataxia with mental retardation (dysequilibrium syndrome). Journal of Child Neurology, 24:1310-1315, Mar 2009. URL: https://doi.org/10.1177/0883073809332696, doi:10.1177/0883073809332696. This article has 80 citations and is from a peer-reviewed journal.
-
(narishige2022twosiblingswith pages 2-4): Yuta Narishige, Hisao Yaoita, Moriei Shibuya, Miki Ikeda, Kaori Kodama, Aritomo Kawashima, Yukimune Okubo, Wakaba Endo, Takehiko Inui, Noriko Togashi, Soichiro Tanaka, Yasuko Kobayashi, Akira Onuma, Jun Takayama, Gen Tamiya, Atsuo Kikuchi, Shigeo Kure, and Kazuhiro Haginoya. Two siblings with cerebellar ataxia, mental retardation, and disequilibrium syndrome 4 and a novel variant of atp8a2. The Tohoku journal of experimental medicine, 256:321-326, Mar 2022. URL: https://doi.org/10.1620/tjem.2022.j010, doi:10.1620/tjem.2022.j010. This article has 13 citations.
-
(flannery2024anovelmissense pages 1-5): Kyle P. Flannery, Sylvia Safwat, Eli Matsell, Namarata Battula, Ahlam A. A. Hamed, Inaam N. Mohamed, Maha A. Elseed, Mahmoud Koko, Rayan Abubaker, Fatima Abozar, Liena E. O. Elsayed, Vikram Bhise, Robert S. Molday, Mustafa A. Salih, Ashraf Yahia, and M. Chiara Manzini. A novel missense variant in the atpase domain of atp8a2 and review of phenotypic variability of atp8a2-related disorders caused by missense changes. Neurogenetics, 25:425-433, Jul 2024. URL: https://doi.org/10.1007/s10048-024-00773-9, doi:10.1007/s10048-024-00773-9. This article has 6 citations and is from a peer-reviewed journal.
-
(matsell2024functionalandin pages 1-3): Eli Matsell, Jens Peter Andersen, and Robert S. Molday. Functional and in silico analysis of atp8a2 and other p4-atpase variants associated with human genetic diseases. Disease Models & Mechanisms, Apr 2024. URL: https://doi.org/10.1242/dmm.050546, doi:10.1242/dmm.050546. This article has 9 citations and is from a domain leading peer-reviewed journal.
-
(matsell2025characterizingthefunctiona pages 108-112): EW Matsell. Characterizing the function of atp8a2 and its role in neurodegenerative disease. Unknown journal, 2025.
-
(onat2012identificationofatp8a2a pages 155-159): OE Onat. Identification of atp8a2 gene mutation in a consaguineous family segregating cerebellar atrophy and quadrupedal gait. Unknown journal, 2012.
-
(paternoster2020novelhomozygousvariant pages 1-2): Lionel Paternoster, Julie Soblet, Alec Aeby, Xavier De Tiège, Serge Goldman, Wyatt W. Yue, Sandra Coppens, Guillaume Smits, Catheline Vilain, and Nicolas Deconinck. Novel homozygous variant of carbonic anhydrase 8 gene expanding the phenotype of cerebellar ataxia, mental retardation, and disequilibrium syndrome subtype 3. American Journal of Medical Genetics Part A, 182:2685-2693, Aug 2020. URL: https://doi.org/10.1002/ajmg.a.61805, doi:10.1002/ajmg.a.61805. This article has 4 citations.
-
(alsahli2018furtherdelineationof pages 3-5): Saud Alsahli, Muhammad Talal Alrifai, Saeed Al Tala, Fuad Al Mutairi, and Majid Alfadhel. Further delineation of the clinical phenotype of cerebellar ataxia, mental retardation, and disequilibrium syndrome type 4. Journal of Central Nervous System Disease, Feb 2018. URL: https://doi.org/10.1177/1179573518759682, doi:10.1177/1179573518759682. This article has 30 citations and is from a peer-reviewed journal.
-
(hochman2025cerebellarataxiaimpaired pages 2-3): Livia Hochman, Alrick Drummond, and Kara Morgan. Cerebellar ataxia, impaired intellectual development, and disequilibrium syndrome-2: a case report. Cureus, Jan 2025. URL: https://doi.org/10.7759/cureus.78066, doi:10.7759/cureus.78066. This article has 0 citations.
-
(onat2012identificationofatp8a2 pages 155-159): OE Onat. Identification of atp8a2 gene mutation in a consaguineous family segregating cerebellar atrophy and quadrupedal gait. Unknown journal, 2012.
Artifacts
Cerebellar Ataxia, Intellectual Disability, and Dysequilibrium (CAMRQ) Deep Research Fallback
Provider Attempts
No interactive deep-research provider artifact was generated for the initial CAMRQ curation. This fallback document records the literature sources that were used to construct the entry, along with the curation conclusions surfaced when addressing claude-review feedback on PR #2696 (issue #2684).
No references_cache/*.md files were hand-edited; all PMIDs cited below were
fetched with just fetch-reference against the live PubMed E-utilities API.
Evidence Scope Used For Curation
- PMID:16080122 (Boycott et al., 2005) — original Hutterite VLDLR homozygous deletion paper. Source for VLDLR/CAMRQ1 identification, inferior cerebellar hypoplasia with cerebral gyral simplification, and the role of VLDLR in Reelin signaling and neuroblast migration.
- PMID:21885617 (Gulsuner et al., 2011, Genome Res) — homozygosity mapping and targeted sequencing identification of WDR81 p.P856L as the cause of cerebro-cerebellar hypoplasia with quadrupedal locomotion in a consanguineous Turkish kindred. Source for human CAMRQ2 genetic evidence, cerebellar peduncle atrophy, and Purkinje-cell-layer WDR81 expression.
- PMID:27390838 (Doldur-Balli et al., 2015, BMC Neurosci) — zebrafish
wdr81 characterization confirming BEACH/WD40 domain architecture and
developmental expression in Purkinje cells. Source for the conserved
endolysosomal/autophagy role tagged
MODEL_ORGANISM. - PMID:31612321 (Mikolajczak et al., 2019) — ATP8A2-related CAMRQ4 phenotype spectrum and functional studies showing loss of phosphatidylserine-activated ATPase activity in missense alleles. Source for CAMRQ4 mechanism and the CAMRQ4-distinguishing global developmental delay / encephalopathy phenotype.
- PMID:38581205 (Kaiyrzhanov et al., 2024, Mov Disord) — clinical and molecular spectrum of autosomal recessive CA8-related cerebellar ataxia (27 patients, 14 families). Source for the CAMRQ3 distinguishing progressive superior vermis atrophy, the CA8 / IP3R1 Purkinje-cell calcium-signaling mechanism, and ca8-knockout zebrafish recapitulation.
- PMID:42051465 (Jawabri et al., 2026, Hum Mutat) — first African family with CAMRQ1, novel VLDLR p.P565Q variant retained in the ER. Source for the CAMRQ-wide clinical signature (cerebellar ataxia, hypotonia, intellectual disability, delayed ambulation, sometimes quadrupedal locomotion) and for the four-gene CAMRQ subtype list.
Curation Conclusions
The accepted disease model is a clinically and genetically heterogeneous group of four autosomal-recessive non-progressive cerebellar disorders (CAMRQ1-4), unified by:
- A convergent neuroanatomical substrate of cerebellar hypoplasia or atrophy with prominent Purkinje cell involvement.
- A convergent clinical phenotype of ataxia, intellectual disability, hypotonia, delayed ambulation, and sometimes quadrupedal locomotion.
- Distinct molecular mechanisms per subtype:
- CAMRQ1 / VLDLR: disrupted Reelin signaling → impaired neuronal migration → cerebellar lamination defect.
- CAMRQ2 / WDR81: BEACH/WD40 endolysosomal-trafficking and selective autophagy defect in Purkinje cells.
- CAMRQ3 / CA8: loss of IP3R1 inhibition by CA8 in Purkinje cells → dysregulated calcium signaling → progressive superior vermis atrophy.
- CAMRQ4 / ATP8A2: loss of P4-type phosphatidylserine flippase activity → loss of neuronal membrane lipid asymmetry.
Mechanistic nodes for all four subtypes converge on a single "Cerebellar Hypoplasia and Purkinje Cell Dysfunction" pathophysiology node whose downstream output is the clinical motor/cognitive dysfunction node.
Notes for Future Refresh
- A live deep-research provider run (e.g.
just research-disorder asta Cerebellar_Ataxia_Intellectual_Disability_and_Dysequilibrium) would be valuable to expand frequency data, MorPhiC/iPSC cellular phenotype coverage, and rare/atypical features (e.g. epilepsy, pyramidal signs in CAMRQ3). - Subtype names use short slug-style identifiers (
CAMRQ1-CAMRQ4) as foreign-key targets per the subtype-naming convention in CLAUDE.md;display_namecarries the verbose form.